Intimations & Announcements
Corporate announcements and regulatory filings with BSE Limited.
BSE Script Code: 540360 | LLFICL | ISIN: INE715Q01029
All filings are submitted to BSE Limited under SEBI LODR Regulations
Notice of Extra-Ordinary General Meeting (EGM)
LatestEGM scheduled for March 18, 2026 at 11:00 AM IST at the registered office. 7 resolutions including preferential issuance of 45 Crore equity shares at Rs. 5/share, increase in authorised capital to Rs. 115 Crores, and appointment of new directors.
Change in Directors / Key Managerial Personnel
Resignation of Mr. Parshottambhai Rupareliya (Non-Executive Chairperson) and Mr. Kurjibhai Rupareliya (Managing Director). Appointment of Mr. Ketankumar Gosai as Managing Director & CFO, Ms. Prity Bishwakarma as Independent Director, and Mr. Deepak Saushi as Non-Executive Director.
Share Capital Increase - Allotment of Equity Shares
Allotment of equity shares pursuant to board approval. Increase in paid-up share capital as part of the company's growth strategy and capital restructuring plan.
Board Meeting Intimation - Preferential Issue
Intimation of board meeting held to consider and approve preferential issue of equity shares, appointment of new directors, and increase in authorised share capital.
Strategic Alliance / Joint Venture Announcement
Announcement regarding strategic alliance to expand business operations and strengthen the company's market presence in the financial services sector.
Compliance Certificate / Regulatory Filing
Submission of regulatory compliance certificate to BSE as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Trading Window Closure Intimation
Intimation regarding closure of trading window for designated persons under SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of financial results.
Board Meeting Intimation - Quarterly Results
Intimation of board meeting to consider and approve unaudited financial results for the quarter ended September 30, 2025.
Board Meeting - Quarterly Financial Results (Q1 FY26)
Board meeting held to consider and approve unaudited standalone financial results for the quarter ended June 30, 2025.
Board Meeting - Audited Annual Results (FY25)
Board meeting held to consider and approve audited standalone financial results for the financial year ended March 31, 2025.
Board Meeting - Quarterly Results (Q3 FY25)
Board meeting to consider and approve unaudited standalone financial results for the quarter ended December 31, 2024.
Board Meeting - Quarterly Results (Q2 FY25)
Board meeting to consider and approve unaudited standalone financial results for the quarter ended September 30, 2024.
Board Meeting - To Consider Issue of Warrants
Board meeting to consider proposal for issuance of warrants on preferential basis.
Board Meeting - General Purpose
Board meeting held for general corporate matters and operational updates.
Board Meeting - Quarterly Results (Q1 FY25)
Board meeting to consider and approve unaudited standalone financial results for the quarter ended June 30, 2024.
Board Meeting - Audited Results & Issue of Warrants (FY24)
Board meeting to consider and approve audited financial results for FY24 and proposal for issue of warrants.
Related Documents
Certificates and reports related to preferential issuance of equity shares and warrants.
For the most up-to-date filings, please visit the BSE website directly.